Skip to main content
About Pfizer Ignite
Our services
Overview
Pre-clinical research & development
Clinical development
Clinical supply and manufacturing
Cross-cutting platforms
Expert advisory network
Our people
Partnerships and Announcements
Contact
Home
Partnerships and Announcements
Announcements
Category
Announcements
Partners
Announcements
Partners
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer
Carrick Therapeutics Announces $35 Million Investment from Pfizer
Anokion Announces $35 Million Equity Investment from Pfizer
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
